Crinetics Pharmaceuticals Operating Income 2017-2024 | CRNX
Crinetics Pharmaceuticals operating income for the twelve months ending September 30, 2024 was $-0.307B, a 47.84% increase year-over-year.
- Crinetics Pharmaceuticals annual operating income for 2023 was $-0.223B, a 32.6% increase from 2022.
- Crinetics Pharmaceuticals annual operating income for 2022 was $-0.168B, a 55.88% increase from 2021.
- Crinetics Pharmaceuticals annual operating income for 2021 was $-0.108B, a 43.69% increase from 2020.